A61K 39/145
Orthomyxoviridae
Official title: Orthomyxoviridae, e.g. influenza virus
A61K39/145 (Orthomyxoviridae) appears on 1,601 US grants and 2,632 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,601
- Published applications
- 2,632
- Assignees
- 1,012
- Inventors
- 4,045
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 6 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 12 | 0 |
| 1998 | 20 | 0 |
| 1999 | 13 | 0 |
| 2000 | 9 | 0 |
| 2001 | 15 | 6 |
| 2002 | 15 | 19 |
| 2003 | 15 | 29 |
| 2004 | 15 | 53 |
| 2005 | 10 | 35 |
| 2006 | 11 | 43 |
| 2007 | 17 | 67 |
| 2008 | 19 | 76 |
| 2009 | 34 | 110 |
| 2010 | 19 | 123 |
| 2011 | 42 | 123 |
| 2012 | 48 | 133 |
| 2013 | 64 | 132 |
| 2014 | 86 | 146 |
| 2015 | 95 | 132 |
| 2016 | 115 | 153 |
| 2017 | 101 | 148 |
| 2018 | 124 | 139 |
| 2019 | 121 | 140 |
| 2020 | 99 | 112 |
| 2021 | 81 | 107 |
| 2022 | 78 | 121 |
| 2023 | 66 | 128 |
| 2024 | 74 | 154 |
| 2025 | 88 | 110 |
| 2026 | 45 | 93 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Lipidated FLIPr and uses thereof in vaccine6 Oct 2026US 12,752,003 B2National Health Research Institutes
- Vaccines, vaccine priming, and antigen dose sparing22 Sep 2026US 12,741,022 B2Adjuvance Technologies, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Combination Vaccine8 Oct 2026US 2026/0306615 A1Seqirus Inc.
- Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation method therefor and use thereof1 Oct 2026US 2026/0294829 A1Cansino Biologics Inc.
Most cited
By later US patents
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Nucleic acid vaccines165US 9,872,900 B2ModernaTX, Inc. · 2018
- Liposome particle containing viral or bacterial antigenic subunit152US 4,235,877 AMerck & Co., Inc. · 1980
- Viral liposome particle151US 4,261,975 AMerck & Co., Inc. · 1981
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999